These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. McLeod HL; Krynetski EY; Relling MV; Evans WE Leukemia; 2000 Apr; 14(4):567-72. PubMed ID: 10764140 [TBL] [Abstract][Full Text] [Related]
13. Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation. Schütz E; Gummert J; Armstrong VW; Mohr FW; Oellerich M Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):199-205. PubMed ID: 8721407 [TBL] [Abstract][Full Text] [Related]
14. Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients. Chadli Z; Hannachi I; Ben Belgacem M; Guediche A; Ben Romdhane H; Kerkeni E; Hamdi L; Slama A; Chaabane A; Ben Fredj N; Boughattas NA; Safer L; Aouam K Pharmacogenomics; 2024; 25(10-11):441-450. PubMed ID: 39382000 [TBL] [Abstract][Full Text] [Related]
15. Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions. Lennard L Ther Drug Monit; 1998 Oct; 20(5):527-31. PubMed ID: 9780130 [TBL] [Abstract][Full Text] [Related]
16. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Bayoumy AB; Ansari AR; Mulder CJJ; Schmiegelow K; Florin T; De Boer NKH Clin Pharmacokinet; 2024 Aug; 63(8):1089-1109. PubMed ID: 39031224 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics. Hartford C; Vasquez E; Schwab M; Edick MJ; Rehg JE; Grosveld G; Pui CH; Evans WE; Relling MV Cancer Res; 2007 May; 67(10):4965-72. PubMed ID: 17510427 [TBL] [Abstract][Full Text] [Related]
18. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783 [TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Yates CR; Krynetski EY; Loennechen T; Fessing MY; Tai HL; Pui CH; Relling MV; Evans WE Ann Intern Med; 1997 Apr; 126(8):608-14. PubMed ID: 9103127 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. Kakuta Y; Kinouchi Y; Shimosegawa T J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]